Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs117353193
rs117353193
TCN2
A 0.710 GeneticVariation GWASCAT Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. 29273593

2018
dbSNP: rs117353193
rs117353193
TCN2
0.710 GeneticVariation BEFREE Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. 29273593

2018
dbSNP: rs2107595
rs2107595 		A 0.710 GeneticVariation GWASCAT Additionally, another SNP associated with MMD (rs2107595 in <i>HDAC9</i>; <i>P</i><sub>combined</sub>=1.49×10<sup>-29</sup>; odds ratio, 1.64) was previously implicated in large-vessel disease. 29273593

2018
dbSNP: rs2107595
rs2107595 		0.710 GeneticVariation BEFREE Additionally, another SNP associated with MMD (rs2107595 in <i>HDAC9</i>; <i>P</i><sub>combined</sub>=1.49×10<sup>-29</sup>; odds ratio, 1.64) was previously implicated in large-vessel disease. 29273593

2018
dbSNP: rs9651118
rs9651118
MTHFR
0.710 GeneticVariation BEFREE Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. 29273593

2018
dbSNP: rs9651118
rs9651118
MTHFR
A 0.710 GeneticVariation GWASCAT Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. 29273593

2018
dbSNP: rs9916351
rs9916351
RNF213
A 0.710 GeneticVariation GWASCAT One SNP, rs9916351 in <i>RNF213</i> (<i>P</i><sub>combined</sub>=4.57×10<sup>-54</sup>; odds ratio, 1.96), showed a stronger genetic effect on early-onset than late-onset MMD (<i>P</i>=0.003). 29273593

2018
dbSNP: rs9916351
rs9916351
RNF213
0.710 GeneticVariation BEFREE One SNP, rs9916351 in <i>RNF213</i> (<i>P</i><sub>combined</sub>=4.57×10<sup>-54</sup>; odds ratio, 1.96), showed a stronger genetic effect on early-onset than late-onset MMD (<i>P</i>=0.003). 29273593

2018
dbSNP: rs10734650
rs10734650
SBF2
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs10782008
rs10782008
RNF213
G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs11640018
rs11640018
CFDP1
G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs118177209
rs118177209
LOC105378178
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs11869363
rs11869363
RNF213
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs16861137
rs16861137
RAPGEF4
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs16862676
rs16862676
TSC22D2
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs201661014
rs201661014
DOCK9
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs2071213
rs2071213
MYRF
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs2262994
rs2262994
NLN
G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs2273291
rs2273291
PLOD1
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs3735925
rs3735925
FBXO25
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs3813803
rs3813803
SMPDL3B
G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs4759277
rs4759277
LRP1
A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs476382
rs476382 		G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs4969426
rs4969426
RPTOR
T 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018
dbSNP: rs61404834
rs61404834 		A 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593

2018